+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Assisted Reproductive Technology Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017-2025

  • ID: 4851723
  • Report
  • January 2018
  • Region: Global
  • 189 pages
  • Transparency Market Research
1 of 2

Global Assisted Reproductive Technology Market: Overview

The report on the assisted reproductive technology market analyzes the current and future scenario of the global market. Increase in prevalence of infertility, advent of new technology for development of new devices for ART procedure for high success rate, and increase in adoption and awareness for IVF and surrogacy, are the major drivers of the global assisted reproductive technology market.

The assisted reproductive technology market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments of the market. It also provides information and data analysis of the global assisted reproductive technology market with respect to the segments based on technology, procedures, end users and geography. A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the market overview section. In addition, the section comprises porters five forces analysis to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis, by geography and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global assisted reproductive technology market.

Global Assisted Reproductive Technology Market: Segmentation

Based on technology type, the assisted reproductive technology market is segmented as in vitro fertilization, artificial insemination, surrogacy and others. The in vitro fertilization is further segmented into intra-cytoplasmic sperm injection (ICSI), and preimplantation genetic diagnosis (PGD). The artificial insemination is segmented into intrauterine insemination (IUI), and intracervical insemination (ICI) and others. The technology market segments have been analyzed based on available approved technology and devices, cost-effectiveness, and preference for technology and procedures by physicians and embryologists. The market size and forecast for each of these segments have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year.

Based on procedures, assisted reproductive technology market is segmented into frozen donor, frozen non donor, fresh donor, fresh non donor, and embryo banking. Based on end user, assisted reproductive technology market is segmented into fertility clinics, hospitals and others. The market segments have been extensively analyzed based on demand for technology and procedure, success rate of procedure and available treatment, and geographical coverage. The market size and forecast in terms of US$ Mn for each segment have been provided for the period from 2015 to 2025. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2017 to 2025, considering 2016 as the base year.

Global Assisted Reproductive Technology Market: Geographical and Competitive Dynamics

Geographically, the global assisted reproductive technology market has been categorized into five major regions and the key countries in the respective region: North America (the U.S., Canada), Europe (the U.K., Germany, Russia, France, Spain, Italy, and Rest of Europe), Asia Pacific (Japan, India, China, Australia & New Zealand and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America) and Middle East & Africa (South Africa, GCC countries and Rest of Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year. The research study also covers the competitive scenario in these regions.

The report also profiles major players in the global assisted reproductive technology market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major players profiled in this report includes Merck KGaA, CooperSurgical, Inc., Irvine Scientific, Vitrolife AB, Hamilton Thorne, Inc., Nidacon International AB, Laboratoire CCD, Planer PLC, Esco Micro Pte. Ltd. (Esco Group), Nikon Corporation and others

Note: Product cover images may vary from those shown
2 of 2
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Assisted Reproductive Technology Market

4. Market Overview
4.1. Introduction
4.2. Overview
4.3. Key Market Indicators
4.4. Market Dynamics
4.4.1. Drivers
4.4.2. Restraints
4.4.3. Opportunity
4.5. Global Assisted Reproductive Technology Market Analysis and Forecasts, 2015-2025
4.5.1. Market Revenue Projections (US$ Mn)
4.6. Assisted Reproductive Technology Market - Global Supply Demand Scenario
4.7. Porter’s Five Force Analysis
4.8. Market Outlook
4.9. Assisted Reproductive Technology: Regional Funding Scenario
4.10. In Vitro Fertilization Costs, by Region, 2016
4.11. Assisted Reproductive Technology: Indication

5. Global Assisted Reproductive Technology Market Analysis and Forecasts, By Technology
5.1. Introduction & Definition
5.2. Key Findings/Developments
5.3. Key Trends
5.4. Market Value Forecast By Technology, 2015-2025
5.4.1. In Vitro Fertilization
5.4.1.1. Intra-cytoplasmic Sperm Injection (ICSI)
5.4.1.2 .Preimplantation Genetic Diagnosis (PGD)
5.4.2. Artificial Insemination
5.4.2.1. Intrauterine Insemination (IUI)
5.4.2.2. Intracervical Insemination (ICI)
5.4.2.3. Others
5.4.3. Surrogacy
5.4.4. Others
5.5. Market Attractiveness By Technology

6. Global Assisted Reproductive Technology Market Analysis and Forecasts, By Procedure
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Key Trends
6.4. Market Value Forecast By Procedure, 2015-2025
6.4.1. Frozen Donor
6.4.2. Frozen Non Donor
6.4.3. Fresh Donor
6.4.4. Fresh Non Donor
6.4.5. Embryo Banking
6.5. Market Attractiveness By Procedure

7. Global Assisted Reproductive Technology Market Analysis and Forecasts, By End User
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Key Trends
7.4. Market Value Forecast By End User, 2015-2025
7.4.1. Fertility Clinics
7.4.2. Hospitals
7.4.3. Others
7.5. Market Attractiveness By End User

8. Global Assisted Reproductive Technology Market Analysis and Forecasts, By Region
8.1. Key Findings
8.2. Policies and Regulations
8.3. Market Value Forecast By Region
8.3.1. North America
8.3.2. Europe
8.3.3. Asia Pacific
8.3.4. Latin America
8.3.5. Middle East and Africa
8.4. Market Attractiveness By Country/Region

9. North America Assisted Reproductive Technology Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.1.2. Policies and Regulations
9.1.3. Key Trends
9.2. Market Value Forecast By Technology , 2015-2025
9.2.1. In Vitro Fertilization
9.2.1.1. Intra-cytoplasmic Sperm Injection (ICSI)
9.2.1.2. Preimplantation Genetic Diagnosis (PGD)
9.2.2. Artificial Insemination
9.2.2.1. Intrauterine Insemination (IUI)
9.2.2.2. Intracervical Insemination (ICI)
9.2.2.3. Others
9.2.3. Surrogacy
9.2.4. Others
9.3. Market Value Forecast By Procedure , 2015-2025
9.3.1. Frozen Donor
9.3.2. Frozen Non Donor
9.3.3. Fresh Donor
9.3.4. Fresh Non Donor
9.3.5. Embryo Banking
9.4. Market Value Forecast By End User , 2015-2025
9.4.1. Fertility Clinics
9.4.2. Hospitals
9.4.3. Others
9.5. Market Value Forecast By Country , 2015-2025
9.5.1. U.S.
9.5.2. Canada
9.6. Market Attractiveness Analysis
9.6.1. By Technology
9.6.2. By Procedure
9.6.3. By End User
9.6.4. By Country

10. Europe Assisted Reproductive Technology Market Analysis and Forecast
10.1.Introduction
10.1.1. Key Findings
10.1.2. Policies and Regulations
10.1.3. Key Trends
10.2.Market Value Forecast By Technology , 2015-2025
10.2.1. In Vitro Fertilization
10.2.1.1. Intra-cytoplasmic Sperm Injection (ICSI)
10.2.1.2. Preimplantation Genetic Diagnosis (PGD)
10.2.2. Artificial Insemination
10.2.2.1. Intrauterine Insemination (IUI)
10.2.2.2. Intracervical Insemination (ICI)
10.2.2.3. Others
10.2.3. Surrogacy
10.2.4. Others
10.3.Market Value Forecast By Procedure , 2015-2025
10.3.1. Frozen Donor
10.3.2. Frozen Non Donor
10.3.3. Fresh Donor
10.3.4. Fresh Non Donor
10.3.5. Embryo Banking
10.4.Market Value Forecast By End User , 2015-2025
10.4.1. Fertility Clinics
10.4.2. Hospitals
10.4.3. Others
10.5.Market Value Forecast By Country , 2015-2025
10.5.1. Germany
10.5.2. France
10.5.3. U.K.
10.5.4. Spain
10.5.5. Italy
10.5.6. Russia
10.5.7. Rest of Europe
10.6.Market Attractiveness Analysis
10.6.1. By Technology
10.6.2. By Procedure
10.6.3. By End User
10.6.4. By Country

11. Asia Pacific Assisted Reproductive Technology Market Analysis and Forecast
11.1.Introduction
11.1.1. Key Findings
11.1.2. Policies and Regulations
11.1.3. Key Trends
11.2.Market Value Forecast By Technology, 2015-2025
11.2.1. In Vitro Fertilization
11.2.1.1.Intra-cytoplasmic Sperm Injection (ICSI)
11.2.1.2.Preimplantation Genetic Diagnosis (PGD)
11.2.2. Artificial Insemination
11.2.2.1.Intrauterine Insemination (IUI)
11.2.2.2.Intracervical Insemination (ICI)
11.2.2.3.Others
11.2.3. Surrogacy
11.2.4. Others
11.3.Market Value Forecast By Procedure, 2015-2025
11.3.1. Frozen Donor
11.3.2. Frozen Non Donor
11.3.3. Fresh Donor
11.3.4. Fresh Non Donor
11.3.5. Embryo Banking
11.4.Market Value Forecast By End User, 2015-2025
11.4.1. Fertility Clinics
11.4.2. Hospitals
11.4.3. Others
11.5.Market Value Forecast By Country, 2015-2025
11.5.1. China
11.5.2. Japan
11.5.3. India
11.5.4. Australia & New Zealand
11.5.5. Rest of Asia Pacific
11.6.Market Attractiveness Analysis
11.6.1. By Technology
11.6.2. By Procedure
11.6.3. By End User
11.6.4. By Country

12. Latin America Assisted Reproductive Technology Market Analysis and Forecast
12.1.Introduction
12.1.1. Key Findings
12.1.2. Policies and Regulations
12.1.3. Key Trends
12.2.Market Value Forecast By Technology , 2015-2025
12.2.1. In Vitro Fertilization
12.2.1.1. Intra-cytoplasmic Sperm Injection (ICSI)
12.2.1.2. Preimplantation Genetic Diagnosis (PGD)
12.2.2. Artificial Insemination
12.2.2.1. Intrauterine Insemination (IUI)
12.2.2.2. Intracervical Insemination (ICI)
12.2.2.3. Others
12.2.3. Surrogacy
12.2.4. Others
12.3.Market Value Forecast By Procedure , 2015-2025
12.3.1. Frozen Donor
12.3.2. Frozen Non Donor
12.3.3. Fresh Donor
12.3.4. Fresh Non Donor
12.3.5. Embryo Banking
12.4.Market Value Forecast By End User , 2015-2025
12.4.1. Fertility Clinics
12.4.2. Hospitals
12.4.3. Others
12.5.Market Value Forecast By Country , 2015-2025
12.5.1. Brazil
12.5.2. Mexico
12.5.3. Rest of Latin America
12.6.Market Attractiveness Analysis
12.6.1. By Technology
12.6.2. By Procedure
12.6.3. By End User
12.6.4. By Country

13. Middle East and Africa Assisted Reproductive Technology Market Analysis and Forecast
13.1.Introduction
13.1.1. Key Findings
13.1.2. Policies and Regulations
13.1.3. Key Trends
13.2.Market Value Forecast By Technology , 2015-2025
13.2.1. In Vitro Fertilization
13.2.1.1. Intra-cytoplasmic Sperm Injection (ICSI)
13.2.1.2. Preimplantation Genetic Diagnosis (PGD)
13.2.2. Artificial Insemination
13.2.2.1. Intrauterine Insemination (IUI)
13.2.2.2. Intracervical Insemination (ICI)
13.2.2.3. Others
13.2.3. Surrogacy
13.2.4. Others
13.3.Market Value Forecast By Procedure , 2015-2025
13.3.1. Frozen Donor
13.3.2. Frozen Non Donor
13.3.3. Fresh Donor
13.3.4. Fresh Non Donor
13.3.5. Embryo Banking
13.4.Market Value Forecast By End User , 2015-2025
13.4.1. Fertility Clinics
13.4.2. Hospitals
13.4.3. Others
13.5.Market Value Forecast By Country , 2015-2025
13.5.1. GCC Countries
13.5.2. South Africa
13.5.3. Rest of Middle East and Africa
13.6.Market Attractiveness Analysis
13.6.1. By Technology
13.6.2. By Procedure
13.6.3. By End User
13.6.4. By Country

14. Competition Landscape
14.1.Market Player - Competition Matrix (By Tier and Size of companies)
14.2.Market Share Analysis By Company (2016)
14.3. ART Service Providers: Market Snapshot
14.4.Company Profiles
14.4.1. Merck KGaA
14.4.1.1 Overview
14.4.1.2 Financials
14.4.1.3.Recent Developments
14.4.1.4 Strategy
14.4.2. CooperSurgical, Inc.
14.4.2.1 Overview
14.4.2.2 Financials
14.4.2.3.Recent Developments
14.4.2.4. Strategy
14.4.3. Irvine Scientific.
14.4.3.1 Overview
14.4.3.2 Financials
14.4.3.3.Recent Developments
14.4.3.4. Strategy
14.4.4. Vitrolife AB.
14.4.4.1 Overview
14.4.4.2 Financials
14.4.4.3.Recent Developments
14.4.4.4. Strategy
14.4.5. Hamilton Thorne, Inc.
14.4.5.1 Overview
14.4.5.2 Financials
14.4.5.3.Recent Developments
14.4.5.4. Strategy
14.4.6. Nikon Corporation
14.4.6.1 Overview
14.4.6.2 Financials
14.4.6.3.Recent Developments
14.4.6.4. Strategy
14.4.7 Nidacon International AB
14.4.7.1 Overview
14.4.7.2 Financials
14.4.7.3.Recent Developments
14.4.7.4. Strategy
14.4.8. Laboratoire CCD
14.4.8.1 Overview
14.4.8.2 Financials
14.4.8.3.Recent Developments
14.4.8.4. Strategy
14.4.9. Planer PLC
14.4.9.1 Overview
14.4.9.2 Financials
14.4.9.3.Recent Developments
14.4.9.4. Strategy
14.4.10. Esco Micro Pte. Ltd. (Esco Group)
14.4.10.1 Overview
14.4.10.2 Financials
14.4.10.3.Recent Developments
14.4.10.4. Strategy
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll